SCNTQ — Scient Income Statement
0.000.00%
TechnologyHighly SpeculativeMicro Cap
- $0.00m
- -$0.19m
- $112.31m
Annual income statement for Scient, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
1997 December 31st | C1998 December 31st | C1999 December 31st | 2000 December 31st | 2001 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K/A |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 19 | 64.8 | 218 | 359 | 112 |
Cost of Revenue | |||||
Gross Profit | 7.64 | 28.8 | 108 | 146 | 6.26 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 35.8 | 112 | 291 | 672 | 289 |
Operating Profit | -16.8 | -47.2 | -72.6 | -312 | -177 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -18.2 | -48.9 | -70.2 | -352 | -164 |
Provision for Income Taxes | |||||
Net Income After Taxes | -15.4 | -48.9 | -70.2 | -352 | -164 |
Net Income Before Extraordinary Items | |||||
Net Income | -15.4 | -48.9 | -70.2 | -352 | -164 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -15.4 | -58 | -91.2 | -352 | -164 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -44.3 | -95.7 | -41.7 | -24.5 | -15.6 |
Dividends per Share |